View in EDS

Leucettine L41 Ameliorates Tau pathology and neuroinflammation in Parkinson's disease models.

Saved in:
Bibliographic Details
Title: Leucettine L41 Ameliorates Tau pathology and neuroinflammation in Parkinson's disease models.
Authors: Hwang S; Data Convergence Drug Research Center, Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon, 34114, Korea.; College of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea., Choi H; Data Convergence Drug Research Center, Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon, 34114, Korea.; College of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea., Cho H; Data Convergence Drug Research Center, Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon, 34114, Korea.; College of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea., Ahn S; Data Convergence Drug Research Center, Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon, 34114, Korea., Yun HY; College of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea. hyyun@cnu.ac.kr., Song JS; Data Convergence Drug Research Center, Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon, 34114, Korea. jssong@krict.re.kr.
Source: BMC neuroscience [BMC Neurosci] 2026 Jul 13. Date of Electronic Publication: 2026 Jul 13.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100966986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-2202 (Electronic) Linking ISSN: 14712202 NLM ISO Abbreviation: BMC Neurosci Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1471-2202
DOI:10.1186/s12868-026-01026-1